Literature DB >> 591632

Occurrence of e antigen in acute hepatitis B.

P E Gibson, K Ruparella.   

Abstract

The occurrence of e antigen in 44 patients with acute hepatitis B was studied in order to determine if e was related to the outcome of the illness. In 13.6% of cases e was detected, and in none of these did the carrier state develop. The HBsAg carrier state developed in 4.6% of the patients and in none of these was e antigen detected. Anti-e was detected in only three cases. Only in the very early acute phase of illness e was detected and the time serum samples were taken for the detection of e was considered to be very significant. The occurrence of e was not found to affect the duration of HBs antigenaemia in those patients who recovered completely.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 591632      PMCID: PMC476595          DOI: 10.1136/jcp.30.10.925

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  8 in total

1.  Incidence and meaning of the "e" determinant among hepatitis-B-antigen positive patients with acute and chronic liver diseases. Report from the Copenhagen Hepatitis Acuta Programme.

Authors:  J O Nielsen; O Dietrichson; E Juhl
Journal:  Lancet       Date:  1974-10-19       Impact factor: 79.321

2.  New specificities in Australia antigen positive sera distinct from the Le Bouvier determinants.

Authors:  L O Magnius; J A Espmark
Journal:  J Immunol       Date:  1972-11       Impact factor: 5.422

3.  e antigen in acute hepatitis B.

Authors:  G Norkrans; L Magnius; S Iwarson
Journal:  Br Med J       Date:  1976-03-27

4.  Incidence and clinical significance of e antigen and antibody in acute and chronic liver disease.

Authors:  N Eleftheriou; H C Thomas; J Heathcote; S Sherlock
Journal:  Lancet       Date:  1975-12-13       Impact factor: 79.321

5.  Behaviour of e antigen and antibody during chronic active liver disease. Relation to HB antigen-antibody system and prognosis.

Authors:  A J Vogten; W H Summerskill; G L Gitnick; S W Schalm; J L Smith; B L Murphy; J E Maynard
Journal:  Lancet       Date:  1976-07-17       Impact factor: 79.321

6.  e antigen and anti-e in HBsAg carriers.

Authors:  S V Feinman; B Berris; J C Sinclair; D M Wrobel; B L Murphy; J E Maynard
Journal:  Lancet       Date:  1975-12-13       Impact factor: 79.321

7.  e Antigen-antibody system as indicator of liver damage in patients with hepatitis-B antigen.

Authors:  N El Sheikh; I L Woolf; R M Galbraith; A L Eddleston; I W Dymock; R Williams
Journal:  Br Med J       Date:  1975-11-01

8.  The relationship between hepatitis B antigen, e-antigen, and liver-pathology in patients treated with dialysis.

Authors:  E Nordenfelt; T Lindholm; H Henrikson
Journal:  Scand J Urol Nephrol       Date:  1975
  8 in total
  2 in total

1.  Persistence of e antigen as prognostic marker in acute hepatitis B.

Authors:  G Pastore; P Dentico; G Angarano; E Lapedota; O Schiraldi
Journal:  Infection       Date:  1979       Impact factor: 3.553

2.  e-Antigen: a link between immune response and infectivity in hepatitis B?

Authors:  G C Turner; H T Green; V D Blundell
Journal:  J Hyg (Lond)       Date:  1978-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.